Regulations.gov document
Interim Response Letter from CDER to Akorn Pharmaceuticals
Other · FDA-2016-P-2375 · posted Jan 27, 2017
Key facts
| Document ID | FDA-2016-P-2375-0004 |
|---|---|
| Title | Interim Response Letter from CDER to Akorn Pharmaceuticals |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2016-P-2375 |
| Posted | Jan 27, 2017 |
| Comment period opens | Jan 27, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: